AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 25,050
+250 (1.01%)
At close: Jul 27, 2026
AprilBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 535,006 | 1,274,137 | 363,457 | 363,525 | 185,346 | - | |
Market Cap Growth | 5.55% | 250.56% | -0.02% | 96.13% | - | - |
Enterprise Value | 452,504 | 1,184,431 | 291,198 | 296,211 | 114,030 | - |
Last Close Price | 22850.00 | 54900.00 | 16200.00 | 16850.00 | 8775.00 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 18.17 | - | - | - |
Forward PE | - | 55.87 | 105.10 | 80.86 | - | - |
PS Ratio | 737.58 | 586.62 | 13.21 | - | 926.73 | - |
PB Ratio | 5.47 | 13.23 | 4.00 | 6.30 | 2.68 | - |
P/TBV Ratio | 5.52 | 13.33 | 4.02 | 6.33 | 2.69 | - |
P/FCF Ratio | - | - | 16.89 | - | - | - |
P/OCF Ratio | - | - | 16.55 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | 545.32 | 10.58 | - | 570.15 | - |
EV/EBITDA Ratio | - | - | 16.57 | - | - | - |
EV/EBIT Ratio | - | - | 17.26 | - | - | - |
EV/FCF Ratio | - | - | 13.54 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.01 | 0.03 | 0.10 | 0.01 | 0.01 |
Debt / EBITDA Ratio | - | - | 0.18 | - | - | 0.07 |
Debt / FCF Ratio | - | - | 0.14 | - | - | 0.14 |
Net Debt / Equity Ratio | -0.84 | -0.96 | -1.00 | -1.00 | -0.99 | -0.94 |
Net Debt / EBITDA Ratio | 9.51 | 14.04 | -5.20 | 4.54 | 6.29 | -10.95 |
Net Debt / FCF Ratio | 19.21 | 25.42 | -4.25 | 5.46 | 10.08 | -21.22 |
Asset Turnover | 0.01 | 0.02 | 0.31 | - | 0.00 | 0.58 |
Quick Ratio | 108.28 | 173.83 | 11.33 | 2.95 | 38.63 | 14.54 |
Current Ratio | 110.34 | 174.90 | 11.39 | 3.07 | 38.81 | 14.68 |
Return on Equity (ROE) | -10.64% | -10.39% | 26.90% | -22.27% | -14.18% | -186.52% |
Return on Assets (ROA) | -5.85% | -4.62% | 11.76% | -11.10% | -10.83% | 6.88% |
Return on Capital Employed (ROCE) | -9.50% | -7.50% | 18.50% | -23.10% | -16.60% | 7.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.89% | -0.76% | 5.50% | -3.89% | -4.83% | - |
FCF Yield | -0.80% | -0.29% | 5.92% | -2.91% | -3.67% | - |
Buyback Yield / Dilution | -2.53% | -3.41% | -2.66% | -9.11% | -134.61% | -139.04% |